Regulatory Clinic Report
Regulatory Clinic Report
The office of Securities and Exchange Board of India (SEBI) office was visited
by our batch on 14th January 2020 as a part of our 1 st Regulatory Clinic. SEBI’s
office is located in Bandra-Kurla Complex, Mumbai (Maharashtra).
Mr. A Ranjan (Assistant General Manager, SEBI) took our session which lasted
for about 2 hours. The session was a Presentation aided interactive one.
ABOUT SEBI
Securities and Exchange Board of India was constituted under the SEBI Act
with the main motives being trifold:
To protect the interest of investors in the securities market
To promote the development of the securities market
To regulate the securities market and the matters connected therewith
For efficient discharge of its functions and fulfil its objectives as stated above
SEBI draws its powers from the underlying legislative act, the SEBI Act of
1992 which was formulated under the Ministry of Finance, though the body was
constituted earlier back in 1998 but the act was passed in the year 1992 only.
Functions of SEBI:
We got the basic understanding of the powers, functions, structure and role
of SEBI in the light of it being a regulatory body and the difference its
existence creates for the financial sector as a whole.
Leant the importance of principles of transparency and accountability in
working of financial sector regulators in efficient discharge of their
fiduciary duty.
Understood the importance of is dynamic responsiveness of the regulator
like SEBI for the discharge of its functions.
Importance of financial autonomy and resource availability for the
regulatory body is vital for it to deliver its functions in an unbiased manner
without external interferences.
Relevance of a feedback loop in the system, in this context the SEBI
SCORES to not only handle the grievances but as also leads to enhanced
adaptability of the regulator.
The office of Securities and Exchange Board of India (SEBI) office was visited
by our batch on 17th January 2020 as a part of our regulatory clinic. Prayas’
office is situated in Kothrud, Pune (Maharashtra).
Ms. Ann Josey (Senior Research Associate), Ms. Manabika Mandal (Research
Associate), Ms. Shweta Kulkarni (Senior Research Associate) and Mr. Ashok
Sreenivas (Senior Fellow) took our session that was presentation aided and
involved real life data monitoring systems used by them.
In this case matter of BEST in truing up of ARR for FY 2017-18 and 2018. The
petition to MERC was filed in November 2019BEST is an undertaking of the
Municipal Corporation of Greater Mumbai (MCGM) and serves the function of
both electricity supply and road transport, electricity is supplied to the areas
from Colaba (South Mumba)i to Sion/Mahim (North Mumbai).
1. The issue of Adani Electricity projecting its tariff based on the Voltage-
wise Cost of Supply (VCoS) instead of Average Cost of Supply (ACoS)
was raised along with the fact that the Tariff should be based strictly on
ACoS but taking into account cost of supply at different Voltage levels as
per the MYT Regulations, 2019
The company had provided a higher cross subsidy to 0-100-units
residential consumers (0-100 units) in comparison to the players
Residential consumers consuming less than 300 units per month have
become cross-subsidising for the first time.
Mr. Pawan Kapoor and Dr. Ashok Pendse raised the matter that the
proposed tariff on residential consumers who consume over 100 units
would be giving them a great burden.
2. Adani electricity has proposed very high capital expenditure and it needs
to be scrutinised whether it under garb of network augmentation and
replacement.
3. The Wheeling Losses and Cross-Subsidy Surcharge (CSS) have being
levied unjustifiably.
The company did not provide any data on the bill generation
efficiency
Many others submitted that the FAC levied to all categories by
Adani Electricity has been much higher than that charged by other
utilities and it was also requested to the Commission to allow only
reasonable and fair amount of FAC to be charged to the consumers.
4. Objections regarding power purchase cost were raised by Tata Power
Company Limited. As per the proposed MYT Petition of AEML-D is
heavily reliant on the short-term / infirm sources of power and has not
presented any Power Purchase plan for the entire Control Period., AEML-
D may have to procure power from real time markets to meet the sudden
demands on account of unpredictability of RE power burden finally
falling on to the consumer.
Fonterra Future Dairy seeks to re-define the dairy market in India by fulfilling a
promise of healthier, richer and more indulgent dairy products - the promise of
Dairy 2.0. In this endeavour they claim to follow one of the most stringent milk
testing regimes in the world.
Fonterra Future Dairy claims to have adopted a risk-based approach for the
management of food safety and quality. They have adopted regulatory standards
compliant with the Hazard Analysis Critical Control Point (HACCP) system to
identify, evaluate and control hazards which are significant to food safety based
on the GFSI certified Food safety management system.
ABOUT THE SESSION
The following session was taken by Mr. Karunakaran which was more of an
interaction based round and we as regulatory governance students were asked
ask questions concerned based on our understanding about the organisation we
gathered in the first session. Before opening the room for questions and
answers, Mr. Karunakaran explained in detail the entire supply chain structure
that Fonterra follows. We got to know about the comparative analysis of the
dairy products in India and New Zealand and dairy practices based on the
parameters like different farm size, productivity, organisation and consolidation.
Some facts highlighted in the session about the dairy industry:
In majorly vegetarian country like India, Milk nearly accounts for 45% of
the protein source for diet.
Specialized characteristics that Milk and other milk products holds in the
cultural and religious practices of the country.
Consumer demand for dairy in India over the next seven years would
probably increase by 82 billion litres — seven times the growth forecast
for China.”
Any dairy conglomerate than has the onus to maintain some very
stringent purity standards from both moral and commercial perspective.
Mr. Karunakaran briefed us about the entire supply chain and then explained us
about the point of adulteration which in this case to our surprise was not at the
source but at the middlemen level. To give a realistic example of how
adulteration happens at source he discussed in detail about Melamine
adulteration case in Chinese markets by Chinese subsidiary of Fonterra adding
to that he also elaborated on the aftermath of the incident where Fonterra
recalled the entire batch produce and has put in place mechanisms like RCA
(Root Cause Analysis) and CAPA (Causal and Prevention Analysis) to tackle
any such issues in future.
On the issues like FSSAI’s permission to add melamine in Indian market he
briefed us about the functioning and economics of the dairy market in India and
how farmers are benefitted with gains due to adulteration of melamine in milk
due to increase in the protein content.
We discussed in detail about the
regulatory concerns of the sector and a
greater need of participatory approach
in deciding and framing the regulatory
regime. The scope of self-regulation in
the sector was also touched upon in the
session as industry primarily needs this
with this.
We also got to know about the in-house
stringent safety practices and standards that Fonterra adheres to and for that
Fonterra has developed a codex that details out the organization response for
various categories of events based on contingencies. To conclude, he also
stressed on the skillset that we need to develop as Regulatory Professionals of
the future. His advice was to focus on impact analysis and causal analysis fields
so as to strengthen the policy analysis domain.
TAKEAWAYS FROM THE SESSION